A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Seve ...
A Phase 2b Randomized, Double-blind, Active-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Induction and Maintenance Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease A Phase 2b Randomized, Double-blind, Active-controlled, Parallel-group, Multicenter Study to Evaluat ...